HIV ribozyme gene therapy - Chiron/Sirna Therapeutics
Latest Information Update: 18 Oct 2007
At a glance
- Originator Sirna Therapeutics
- Class Antivirals; Gene therapies; Ribozyme genes
- Mechanism of Action Ribonuclease stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 17 Apr 2000 Suspended-II for HIV-1 infections in USA (Unknown route)
- 04 Dec 1997 Phase-II clinical trials for HIV-1 infections in USA (Unknown route)